Arbutus Biopharma Corporation
NASDAQ: ABUSWarminster, US · British Columbia, Canada corporation · 45 employees on LinkedIn · 1 known investors
Arbutus is a biotechnology company developing therapeutic assets and bringing them to market, with expertise spanning scientific, clinical, operational, and financial development. It focuses on drug development, partnerships, and licensing deals within the biopharma sector.
Founders & leadership
WH
William H. CollierPresident and Chief Executive Officer
GP
Gaston PicchioChief Development Officer
MJ
Michael J. McElhaughChief Business Officer
DC
David C. HastingsChief Financial Officer
MJ
Michael J. SofiaChief Scientific Officer
EH
Elizabeth HowardExecutive
LA
Lindsay AndroskiPresident & CEO and Chairperson
TN
Tuan NguyenChief Financial Officer
AJ
Andrew J. SungGeneral Counsel
Board
EV
Eric VenkerBoard director
FT
Frank TortiChairman
AC
Andrew ChengBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$15M disclosed across 1 round · 2016
▶$15MraisedDec 2021 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedDec 2021 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Andrew ChengDirector
- Eric VenkerDirector
- William H. CollierExecutive Officer, Director
- Gaston PicchioExecutive Officer
- Michael J. McElhaughExecutive Officer
- Frank TortiDirector
- Daniel BurgessDirector
- David C. HastingsExecutive Officer
- Michael J. SofiaExecutive Officer
- James MeyersDirector
- Elizabeth HowardExecutive Officer
- Tram TranDirector
- Richard C. HenriquesDirector
- Keith ManchesterDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Dec 2016
- Incorporated
- Corporation, British Columbia, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapAgenus43 shared keywords
Robinhood40 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Amicus Therapeutics37 shared keywordsAmicus is a rare disease biotechnology company developing medicines for people with genetically defined conditions. It operates as a wholly owned subsidiary of BioMarin Pharmaceutical Inc.
Seeking Alpha33 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Arbutus Biopharma Corporation for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Arbutus Biopharma Corporation do?
- Arbutus is a biotechnology company developing therapeutic assets and bringing them to market, with expertise spanning scientific, clinical, operational, and financial development. It focuses on drug development, partnerships, and licensing deals within the biopharma sector.
- Who are Arbutus Biopharma Corporation's investors?
- Arbutus Biopharma Corporation's investors include Foresite Capital.
- How much funding has Arbutus Biopharma Corporation raised?
- Arbutus Biopharma Corporation has disclosed $15M raised across 1 round.
- Where is Arbutus Biopharma Corporation headquartered?
- Arbutus Biopharma Corporation is headquartered in Warminster, US.